{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:30:00Z","timestamp":1790206200230,"version":"4.1.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,15]]},"DOI":"10.1093\/cid\/cix178","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T20:11:06Z","timestamp":1487794266000},"page":"1422-1429","source":"Crossref","is-referenced-by-count":66,"title":["Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection"],"prefix":"10.1093","volume":"64","author":[{"given":"Jordan E.","family":"Lake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takara L.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Apovian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalendar","family":"Bhasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"Capeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith S.","family":"Currier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Dube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Falutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Grinspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guaraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"McComsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred R.","family":"Sattler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine M.","family":"Erlandson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,24]]},"reference":[{"key":"key\n\t\t\t\t20170512154548_CIT0001","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/aid.2015.0147","article-title":"Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada","volume":"32","author":"North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170512154548_CIT0002","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1097\/QAI.0000000000000010","article-title":"High risk of obesity and weight gain for HIV-infected uninsured minorities","volume":"65","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170512154548_CIT0003","doi-asserted-by":"crossref","first-page":"ofu040","DOI":"10.1093\/ofid\/ofu040","article-title":"Obesity trends and body mass index changes after starting antiretroviral treatment: The Swiss HIV Cohort Study","volume":"1","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20170512154548_CIT0004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12981-016-0094-y","article-title":"High prevalence of being overweight and obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial","volume":"13","year":"2016","journal-title":"AIDS Res Ther"},{"key":"key\n\t\t\t\t20170512154548_CIT0005","doi-asserted-by":"crossref","first-page":"19033","DOI":"10.7448\/IAS.18.1.19033","article-title":"HIV\/AIDS and lipodystrophy: implications for clinical management in resource-limited settings","volume":"18","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20170512154548_CIT0006","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/apc.2016.0183","article-title":"Changes in body fat distribution on dual-energy x-ray absorptiometry in black South Africans starting first-line antiretroviral therapy","volume":"30","year":"2016","journal-title":"AIDS Patient Care STDS"},{"key":"key\n\t\t\t\t20170512154548_CIT0007","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","article-title":"HIV lipodystrophy: prevalence, severity and correlates of risk in Australia","volume":"4","year":"2003","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170512154548_CIT0008","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1514009","article-title":"Mechanisms, pathophysiology, and management of obesity","volume":"376","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170512154548_CIT0009","volume-title":"Obesity and overweight fact sheet","year":"2016"},{"key":"key\n\t\t\t\t20170512154548_CIT0010","article-title":"Obesity practice essentials","volume-title":"Medscape","year":"2016"},{"key":"key\n\t\t\t\t20170512154548_CIT0011","article-title":"Lipodystrophy in HIV","volume-title":"Medscape","year":"2016"},{"key":"key\n\t\t\t\t20170512154548_CIT0012","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3945\/ajcn.2009.28595","article-title":"Increased food energy supply is more than sufficient to explain the US epidemic of obesity","volume":"90","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t20170512154548_CIT0013","volume-title":"Obesity risk factors","year":"2015"},{"key":"key\n\t\t\t\t20170512154548_CIT0014","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1474-9726.2010.00608.x","article-title":"Fat tissue, aging, and cellular senescence","volume":"9","year":"2010","journal-title":"Aging Cell"},{"key":"key\n\t\t\t\t20170512154548_CIT0015","first-page":"327","article-title":"Gut microbiota: modulation of host physiology in obesity","volume":"31","year":"2016","journal-title":"Physiology (Bethesda)"},{"key":"key\n\t\t\t\t20170512154548_CIT0016","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","year":"2006","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170512154548_CIT0017","doi-asserted-by":"crossref","first-page":"e39748","DOI":"10.1371\/journal.pone.0039748","article-title":"Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170512154548_CIT0018","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","year":"2007","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170512154548_CIT0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2016.06.023","article-title":"Microbially produced acetate: a \u201cmissing link\u201d in understanding obesity?","volume":"24","year":"2016","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20170512154548_CIT0020","first-page":"55","article-title":"The role of gut microflora and the cholinergic anti-inflammatory neuroendocrine system in diabetes mellitus","volume":"7","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key\n\t\t\t\t20170512154548_CIT0021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13098-016-0156-2","article-title":"Visceral adiposity syndrome","volume":"8","year":"2016","journal-title":"Diabetol Metab Syndr"},{"key":"key\n\t\t\t\t20170512154548_CIT0022","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1210\/jc.2015-1461","article-title":"RAAS activation is associated with visceral adiposity and insulin resistance among HIV-infected patients","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170512154548_CIT0023","doi-asserted-by":"crossref","first-page":"e004043","DOI":"10.1161\/CIRCIMAGING.115.004043","article-title":"Relationship between measures of adiposity, arterial inflammation, and subsequent cardiovascular events","volume":"9","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"key\n\t\t\t\t20170512154548_CIT0024","doi-asserted-by":"crossref","first-page":"E439","DOI":"10.1002\/oby.20135","article-title":"Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults","volume":"21","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"key\n\t\t\t\t20170512154548_CIT0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.gastro.2015.05.044","article-title":"Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease","volume":"149","year":"2015","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170512154548_CIT0026","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/QAI.0b013e31829bdb67","article-title":"Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy","volume":"64","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170512154548_CIT0027","doi-asserted-by":"crossref","first-page":"e1005153","DOI":"10.1371\/journal.ppat.1005153","article-title":"Adipose tissue is a neglected viral reservoir and an inflammatory site during chronic HIV and SIV infection","volume":"11","year":"2015","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170512154548_CIT0028","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/QAI.0b013e31825c3a68","article-title":"Adipogenic\/lipid, inflammatory, and mitochondrial parameters in subcutaneous adipose tissue of untreated HIV-1-infected long-term nonprogressors: significant alterations despite low viral burden","volume":"61","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170512154548_CIT0029","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4161\/adip.29852","article-title":"Viral mechanisms of adipose dysfunction: lessons from HIV-1 Vpr","volume":"4","year":"2015","journal-title":"Adipocyte"},{"key":"key\n\t\t\t\t20170512154548_CIT0030","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1210\/jc.2015-3993","article-title":"Dysfunctional subcutaneous fat with reduced dicer and brown adipose tissue gene expression in HIV-infected patients","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170512154548_CIT0031","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/QAI.0000000000000001","article-title":"CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in antiretroviral therapy-treated virologically suppressed HIV-infected patients","volume":"64","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170512154548_CIT0032","first-page":"504","article-title":"Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170512154548_CIT0033","first-page":"2873","article-title":"RAAS activation is associated with visceral adiposity and insulin resistance among HIV-infected patients","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170512154548_CIT0034","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00018-015-2061-5","article-title":"Gut microbiota and obesity","volume":"73","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"key\n\t\t\t\t20170512154548_CIT0035","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170512154548_CIT0036","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection","volume":"14","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170512154548_CIT0037","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/hiv.12159","article-title":"The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection","volume":"15","year":"2014","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170512154548_CIT0038","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw017","article-title":"Body composition changes after initiation of raltegravir or protease inhibitors: ACTG A5260s","volume":"62","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170512154548_CIT0039","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/cid\/cir324","article-title":"Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG study A5224s","volume":"53","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170512154548_CIT0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11904-016-0298-8","article-title":"Fat matters: understanding the role of adipose tissue in health in HIV infection","volume":"13","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key\n\t\t\t\t20170512154548_CIT0041","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molmed.2010.03.002","article-title":"HIV-associated lipodystrophy: from fat injury to premature aging","volume":"16","year":"2010","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t20170512154548_CIT0042","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3851\/IMP1988","article-title":"Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes","volume":"17","year":"2012","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170512154548_CIT0043","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ajpath.2011.07.049","article-title":"LMNA mutations induce a non-inflammatory fibrosis and a brown fat-like dystrophy of enlarged cervical adipose tissue","volume":"179","author":"Lipodystrophy Study Group","year":"2011","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170512154548_CIT0044","doi-asserted-by":"crossref","first-page":"e0136571","DOI":"10.1371\/journal.pone.0136571","article-title":"The molecular signature of HIV-1-associated lipomatosis reveals differential involvement of brown and beige\/brite adipocyte cell lineages","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170512154548_CIT0045","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.2174\/138161210793563446","article-title":"Adipose tissue as a target of HIV-1 antiretroviral drugs. Potential consequences on metabolic regulations","volume":"16","year":"2010","journal-title":"Curr Pharm Des"},{"key":"key\n\t\t\t\t20170512154548_CIT0046","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S1473-3099(13)70271-8","article-title":"Metabolic disease in HIV infection","volume":"13","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170512154548_CIT0047","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","article-title":"Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment","volume":"23","author":"AIDS Clinical Trials Group (ACTG) A5142 Study Team","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170512154548_CIT0048","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1468-1293.2011.00941.x","article-title":"Randomized comparison of metabolic and renal effects of saquinavir\/r or atazanavir\/r plus tenofovir\/emtricitabine in treatment-na\u00efve HIV-1-infected patients","volume":"12","author":"BASIC Study Group","year":"2011","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170512154548_CIT0049","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40261-014-0175-4","article-title":"Comparison of body composition changes between atazanavir\/ritonavir and lopinavir\/ritonavir each in combination with tenofovir\/emtricitabine in antiretroviral-na\u00efve patients with HIV-1 infection","volume":"34","year":"2014","journal-title":"Clin Drug Investig"},{"key":"key\n\t\t\t\t20170512154548_CIT0050","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/cid\/ciu898","article-title":"Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial","volume":"60","author":"ATADAR Study Group","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170512154548_CIT0051","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/hiv.12178","article-title":"Body mass index and the risk of incident noncommunicable diseases after starting antiretroviral therapy","volume":"16","year":"2015","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170512154548_CIT0052","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","year":"2006","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170512154548_CIT0053","first-page":"18","article-title":"The relationship of obesity to the metabolic syndrome","year":"2003","journal-title":"Int J Clin Pract Suppl"},{"key":"key\n\t\t\t\t20170512154548_CIT0054","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/infdis\/jiw096","article-title":"Inflammation and change in body weight with antiretroviral therapy initiation in a multinational cohort of HIV-infected adults","volume":"214","author":"ACTG PEARLS and NWCS 319 Study Team","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170512154548_CIT0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13104-016-1953-2","article-title":"Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia","volume":"9","year":"2016","journal-title":"BMC Res Notes"},{"key":"key\n\t\t\t\t20170512154548_CIT0056","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1871530315666150907111120","article-title":"Nutritional status and lipid profile in HIV-infected adults","volume":"15","year":"2015","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"key\n\t\t\t\t20170512154548_CIT0057","first-page":"803095","article-title":"Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial","volume":"2014","year":"2014","journal-title":"Mediators Inflamm"},{"key":"key\n\t\t\t\t20170512154548_CIT0058","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/QAD.0b013e32834884e6","article-title":"Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection","volume":"25","author":"Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM)","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170512154548_CIT0059","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/09540121.2010.543885","article-title":"Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study","volume":"23","year":"2011","journal-title":"AIDS Care"},{"key":"key\n\t\t\t\t20170512154548_CIT0060","doi-asserted-by":"crossref","first-page":"ofw098","DOI":"10.1093\/ofid\/ofw098","article-title":"anatomic fat depots and coronary plaque among human immunodeficiency virus-infected and uninfected men in the Multicenter AIDS Cohort Study","volume":"3","year":"2016","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/10\/1422\/17827856\/cix178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T16:38:47Z","timestamp":1719074327000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cix178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,24]]},"references-count":60,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,2,24]]},"published-print":{"date-parts":[[2017,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix178","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,24]]}}}